ASM Policy efforts focus on communicating the importance of the microbial science to Congress, Federal Agencies and the Public.

On Friday, September 14, The Pew Charitable Trusts hosted FDA Commissioner Scott Gottlieb announced the agency’s approach to reducing antimicrobial resistance (AMR) through antibiotic stewardship and innovation. 

The Centers for Medicare and Medicaid Services (CMS) subcontractor Palmetto MolDX has finalized its Local Coverage Determination (LCD) for Multiplex Nucleic Acid Amplified Tests (NAATs) for Respiratory Viral Panels.

The American Clinical Laboratory Association (ACLA), a trade association representing clinical laboratories, challenged a regulation issued by the Secretary of the U.S. Department of Health and Human Services (DHHS), specifically, Section 216 of the Protecting Access to Medicare Act of 2014 (“PAMA”).

ASM applauds the House on passing the FY19 Labor-HHS Bill, which includes a $2 billion increase for the National Institutes of Health (NIH) and an increase of $127 million for the Centers for Disease Control and Prevention.

We urge House members to vote in favor of the bill and encourage swift Senate passage of the bill, including the PACCARB provision.

VITEK 2 Gram-Positive AST Cards Recalled Due to False Results for Some MRSA Strains: What Can Your Laboratory Do?

The report provides the most recent nationwide data on antibiotic resistance transmitted commonly by food.

Thursday, 23 August 2018 09:54

ASM Attends CPT® Editorial Panel Meeting

Coding and Reimbursement subcommittee member Amy Peace-Brewer represented ASM at the Current Procedural Terminology (CPT®) Editorial Panel on August 9.

ASM joined organizations representing laboratories, diagnostic manufacturers, health care professionals, and patients to urge Congress to take immediate action to address the harmful cuts to the Clinical Laboratory Fee Schedule (CLFS).

On July 26, ASM joined the Clinical Laboratory Coalition (CLC) in a conference call to update members on current strategies to reverse the detrimental effects of the Protecting Access to Medicare Act of 2014 (PAMA) legislation, which will reduce laboratory test reimbursement.

On July 25, the Health Subcommittee of the House Energy and Commerce Committee held a hearing on implementation of the “21st Century Cures Act (Cures Act).” National Institutes of Health (NIH) Director Francis Collins and U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb were among the witnesses. Rep. Gene Green (D-TX) expressed concern with antibiotic resistance and development of an Ebola vaccine and Rep. Anna Eshoo (D-CA) asked about the priority review process for medical countermeasures (MCM).

ASM thanks the House Energy and Commerce Committee for its passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018.

ASM joined members of the Clinical Laboratory Coalition in a letter to House and Senate committee leadership on the Diagnostic Accuracy and Innovation Act (DAIA) discussion draft.

ASM staff joined the Global Health Council and other stakeholders in a meeting with Robert Redfield to discuss broad priorities for the CDC in the coming years.

ASM submitted comments to the Centers for Medicare and Medicaid Services on payment for new codes which will be included in the 2019 Medicare Clinical Laboratory Fee Schedule (CLFS). New codes considered include several Borrelia diagnostic tests.

ASM joins laboratory societies in two letters on the Palmetto Draft Local Coverage Determinations on Multiplex Nucleic Acid Amplified Tests for Respiratory and Gastrointestinal Panels.

The ASM calls upon Congress to continue to make available the
balance of FY 2015 Ebola emergency funding, and to work through the FY 2019 appropriations
process to create a robust public health emergency contingency fund that allows the United
States to respond rapidly to Ebola and other pandemics that threaten our homeland.

The ASM Office of Public Affairs has prepared a document explaining science-related spending in the fiscal year 2018 Omnibus Spending Bill.

ASM drafted comments to the Centers for Medicare & Medicaid Services on Clinical Laboratory Improvement Amendments of 1988 (CLIA) personnel requirements and appropriate sanctions in situations where they determine that a laboratory has referred its proficiency testing samples to another laboratory.  ASM strongly recommends that all laboratory testing personnel meet the 24 semester hour science requirement for high complexity testing. 

The American Society for Microbiology issued the following statement in response to the President’s fiscal year (FY) 2019 budget released yesterday.

Page 1 of 6